Innovation is part of our DNA at CHOP and we are thrilled to share that we have been recognized as one of FastCompany’s Most Innovative Companies of 2026, leading the healthcare category. We are grateful to our amazing employees for making our breakthroughs possible, from creating the first FDA-approved cell and gene therapy to treating the world’s first patient with personalized gene-editing therapy, our team is advancing healthcare for children one extraordinary discovery at a time. Learn more about innovation at CHOP at the link in our bio. #FCMostInnovative